Jang Yoon-jung’s Mother Allegedly Used Her Estranged Daughter’s Name in an Investment Scam
Victims' Side: "We Haven't Received a Refund of Our 30 Million Won Investment"
Jang Yoon-jung's Representative: "Jang Yoon-jung Has Not Been in Contact with Her Mother"
[Edaily Starin KIM HYUNSIK Reporter] Allegations have surfaced that Ms. A, the mother of singer Jang Yoon-jung, committed fraud by using her daughter’s name despite having cut ties with her. Jang Yoon-jung (Photo = Edaily DB)
In its broadcast on the 30th, JTBC’s “Case Squad” covered the story of Ms. B, a woman in her 60s who claims she was the victim of an investment scam perpetrated by Ms. A, Jang Yoon-jung’s mother. Ms. B claimed that Ms. A deceived her by claiming to be in contact with Jang Yoon-jung and promising she could earn a large sum of money by investing in TV Chosun’s “Mr. Trot.” She alleged that she handed over 30 million won but has not received a refund. “Case Squad” reported that Ms. B’s daughter filed a criminal complaint against Ms. A on charges of fraud last April, and that there is another victim who claims to have been defrauded using a similar scheme. Jang Yoon-jung’s representatives issued a statement through “Case Squad,” saying, “Jang Yoon-jung has never communicated directly with her mother,” and added, “Although her mother attempted to contact her several times through acquaintances, Jang Yoon-jung did not respond.” Meanwhile, Jang Yoon-jung revealed in 2013 that her mother, Ms. A, and her younger brother had squandered all the money she had earned from her singing career and left her with 1 billion won in debt. Following a legal battle, she subsequently announced that she had severed ties with her mother.
The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…